Litchev Boyan Vesselinov 4
4 · Indaptus Therapeutics, Inc. · Filed Dec 19, 2022
Insider Transaction Report
Form 4
Litchev Boyan Vesselinov
Chief Medical Officer
Transactions
- Purchase
Common Stock
2022-11-22$1.83/sh+500$915→ 650 total - Purchase
Common Stock
2022-01-31$4.65/sh+100$465→ 100 total - Purchase
Common Stock
2022-03-02$4.09/sh+50$205→ 150 total - Purchase
Common Stock
2022-12-01$1.87/sh+500$935→ 1,150 total